Masimo Research and Development Expenses 2010-2024 | MASI
Masimo annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Masimo research and development expenses for the quarter ending December 31, 2024 were $0.078B, a 104.47% increase year-over-year.
- Masimo research and development expenses for the twelve months ending December 31, 2024 were $0.223B, a 27.17% increase year-over-year.
- Masimo annual research and development expenses for 2024 were $0.223B, a 27.17% increase from 2023.
- Masimo annual research and development expenses for 2023 were $0.175B, a 8.46% decline from 2022.
- Masimo annual research and development expenses for 2022 were $0.191B, a 39.5% increase from 2021.
| Masimo Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $223 |
| 2023 | $175 |
| 2022 | $191 |
| 2021 | $137 |
| 2020 | $119 |
| 2019 | $93 |
| 2018 | $81 |
| 2017 | $65 |
| 2016 | $58 |
| 2015 | $57 |
| 2014 | $57 |
| 2013 | $56 |
| 2012 | $47 |
| 2011 | $38 |
| 2010 | $36 |
| 2009 | $32 |
| Masimo Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $78 |
| 2024-09-30 | $48 |
| 2024-06-30 | $49 |
| 2024-03-31 | $48 |
| 2023-12-31 | $38 |
| 2023-09-30 | $47 |
| 2023-06-30 | $40 |
| 2023-03-31 | $51 |
| 2022-12-31 | $54 |
| 2022-09-30 | $53 |
| 2022-06-30 | $48 |
| 2022-03-31 | $36 |
| 2021-12-31 | $33 |
| 2021-09-30 | $35 |
| 2021-06-30 | $34 |
| 2021-03-31 | $35 |
| 2020-12-31 | $32 |
| 2020-09-30 | $29 |
| 2020-06-30 | $31 |
| 2020-03-31 | $27 |
| 2019-12-31 | $23 |
| 2019-09-30 | $24 |
| 2019-06-30 | $24 |
| 2019-03-31 | $21 |
| 2018-12-31 | $21 |
| 2018-09-30 | $21 |
| 2018-06-30 | $20 |
| 2018-03-31 | $20 |
| 2017-12-31 | $19 |
| 2017-09-30 | $15 |
| 2017-06-30 | $16 |
| 2017-03-31 | $14 |
| 2016-12-31 | $13 |
| 2016-09-30 | $16 |
| 2016-06-30 | $15 |
| 2016-03-31 | $14 |
| 2015-12-31 | $14 |
| 2015-09-30 | $14 |
| 2015-06-30 | $13 |
| 2015-03-31 | $15 |
| 2014-12-31 | $15 |
| 2014-09-30 | $14 |
| 2014-06-30 | $13 |
| 2014-03-31 | $14 |
| 2013-12-31 | $14 |
| 2013-09-30 | $14 |
| 2013-06-30 | $14 |
| 2013-03-31 | $14 |
| 2012-12-31 | $13 |
| 2012-09-30 | $12 |
| 2012-06-30 | $11 |
| 2012-03-31 | $11 |
| 2011-12-31 | $10 |
| 2011-09-30 | $9 |
| 2011-06-30 | $9 |
| 2011-03-31 | $10 |
| 2010-12-31 | $8 |
| 2010-09-30 | $9 |
| 2010-06-30 | $9 |
| 2010-03-31 | $9 |
| 2009-12-31 | $9 |
| 2009-09-30 | $8 |
| 2009-06-30 | $7 |
| 2009-03-31 | $8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $8.993B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||